Adherence to therapy: Using an evidence-based protocol

Rehabilitation Nursing

Volumn 32, Issue 6, 2007, Pages 227-232

  Moore, Linda A ^a   Kaufman, Michael D ^b   Algozzine, Robert ^a   Irish, Nikki ^e   Martin, Mary ^c   Posey, Carol Rosser ^d  

^a UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE   (United States)

^b MS Center   (United States)

^c Raleigh University   (United States)

^d Advanced Occupational Health Services

^e Advanced Occupational Health Services ^*

Author keywords

Adherence to injection; Injection site reaction; Multiple sclerosis

Indexed keywords

EID: 37549048642     PISSN: 02784807     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.2048-7940.2007.tb00179.x     Document Type: Article

References (16)

1. Compston, A., Ebers, G., Lassmann, H., McDonald, I., Matthews, B., & Wekerle, H. (1999). McAlpine's multiple sclerosis (3rd ed.). New York: Churchill Livingstone.
2. Gaines, A. R., & Varricchio, F. (1998). Interferon beta-1b injection site reactions and necroses. Multiple Sclerosis, 4, 70-73.
3. Glantz, S.A. (2005). Primer of biostatistics (6th ed.). New York: McGraw-Hill.
4. Halper, J. (2002). Pharmacotherapeutics in multiple sclerosis and nursing implications. In J. Halper & N. Holland (Eds.) Comprehensive nursing care in multiple sclerosis. (pp. 175-182). New York: Demos Medical.
5. Halper, J., Harris, C., & Machler, B. (2005). Managing injection-site reactions in patients with MS. Multiple Sclerosis Counseling Points, 1, 1-10.
6. Inafuku, H., Kasem, K., Nagata, T., & Nonaka, S. (2004). Cutaneous ulcerations following subcutaneous interferon beta injection to a patient with multiple sclerosis. Journal of Dermatology, 31, 671-677.
7. Knobler, R. L., Kelley, C. L., Trantas, F., Webster, G. F., & Lublin, F. D. (1994). Interferon beta 1-b induced ulcerative skin lesions in MS. Journal of Neuroimmunology, 54, 173.
8. Kozier, B., Erb, G., & Blais, K. (2000). Fundamentals of nursing: Concepts, process and practice (6th ed.). Upper Saddle River, NJ: Prentice Hall Health.
9. Kraemer, H. C., & Theimann, S. (1987). How many subjects: Statistical power-analysis in research. Newbury Park, CA: Sage.
10. Mohr, D. C., Goodkin, D. E., Likosky, W., Gatto, N., Neilley, L. K., Griffin, C., et al. (1996). Therapeutic expectations of patients with multiple sclerosis upon initiating interferon beta-1b: Relationship to adherence to treatment. Multiple Sclerosis, 2, 222-226.
11. Moore, L. A. (2003). Correlations of injection reactions to BMI and to anthropometric measures. [Abstract]. International Journal of MS Care, 5, 114.
12. Namey, M. A. (2001). Promoting adherence to complex protocols. In J. Halper (Ed.), Advanced concepts in multiple sclerosis nursing care. New York: Demos Medical.
13. 2007 Physicians' Desk Reference. (61st ed.). (2006). Montvale, NJ: Thomson.
14. Samuel, L., & Lowenstein, E. J. (2006). Recurrent injection site reactions from interferon beta 1-b. Journal of Drugs in Dermatology, 5, 366-367.
15. Seidel, H. M., Ball, J. W., Dains, J. E., & Benedict, G. W. (1999). Mosby's guide to physical examination (4th ed.). St. Louis, MO: Mosby.
16. Walther, E. U., & Hohlfeld, R. (1999). Multiple sclerosis: Side effects of interferon beta therapy and their management. Neurology, 53(8), 1622-1627.